BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes
| | | | | Mixed |
BRMS1 | Breast cancer metastasis suppressor 1 | Cancer-related genes
| | | | | Expressed in all |
BTG2 | BTG family, member 2 | Cancer-related genes
| | | | | Expressed in all |
C18orf8 | Chromosome 18 open reading frame 8 | Cancer-related genes
| | | | | Expressed in all |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
C7 | Complement component 7 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA8 | Carbonic anhydrase VIII | Cancer-related genes Disease related genes
| | | | | Mixed |
CALCA | Calcitonin-related polypeptide alpha | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM3 | Calmodulin 3 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPN6 | Calpain 6 | Cancer-related genes Enzymes
| | | | | Tissue enriched |
CASC3 | Cancer susceptibility candidate 3 | Cancer-related genes Transporters
| | | | | Expressed in all |
CASP1 | Caspase 1, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CASP10 | Caspase 10, apoptosis-related cysteine peptidase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASP2 | Caspase 2, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASP4 | Caspase 4, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Group enriched |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CASP7 | Caspase 7, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASP9 | Caspase 9, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes
| | | | | Mixed |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CCL11 | Chemokine (C-C motif) ligand 11 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
CCL13 | Chemokine (C-C motif) ligand 13 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
CCL14 | Chemokine (C-C motif) ligand 14 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL16 | Chemokine (C-C motif) ligand 16 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CCL18 | Chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL2 | Chemokine (C-C motif) ligand 2 | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL23 | Chemokine (C-C motif) ligand 23 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
CCL3 | Chemokine (C-C motif) ligand 3 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL4 | Chemokine (C-C motif) ligand 4 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL5 | Chemokine (C-C motif) ligand 5 | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CCL7 | Chemokine (C-C motif) ligand 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CCL8 | Chemokine (C-C motif) ligand 8 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
CCNA1 | Cyclin A1 | Cancer-related genes
| | | | | Group enriched |
CCNA2 | Cyclin A2 | Cancer-related genes
| | | | | Mixed |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |